Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Jan;44(1):64–68. doi: 10.1136/jcp.44.1.64

Serum non-organ specific autoantibodies in human immunodeficiency virus 1 infection.

F Cassani 1, L Baffoni 1, E Raise 1, L Selleri 1, M Monti 1, L Bonazzi 1, F M Gritti 1, F B Bianchi 1
PMCID: PMC497018  PMID: 1671787

Abstract

Serum samples from 66 seropositive subjects (56 with a history of intravenous drug abuse), including asymptomatic carriers and patients with persistent generalised lymphadenopathy (PGL), AIDS related complex (ARC), and AIDS, were tested by indirect immunofluorescence on rat tissue sections and HEp-2 cells for the presence of antibodies to nuclei, smooth muscle, intermediate filaments (anti-IMF) and microfilaments (anti-MF). Counterimmunoelectrophoresis was also used to detect antibodies to extractable nuclear antigens. Smooth muscle antibodies with the V pattern or antinuclear antibodies, mainly of the speckled type, or anti-IMF, occurred in 35 cases, being widely distributed in all groups. Such an autoantibody response resembles the "viral" autoimmunity described in various infectious diseases and in particular that of non-A, non-B post-transfusion hepatitis. Autoantibodies may be of some prognostic relevance, as the prevalence of smooth muscle antibodies V increased as the disease progressed (asymptomatic carriers 20%, those with PGL 29%, those with ARC 47%, and those with AIDS 63%. In the PGL group autoantibody positivity correlated with the presence of skin anergy. The fact that autoantibodies were more frequently detected in patients with circulating immune complexes suggests that these can contain autoantibodies and the corresponding autoantigens.

Full text

PDF
64

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein R. M., Steigerwald J. C., Tan E. M. Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis. Clin Exp Immunol. 1982 Apr;48(1):43–51. [PMC free article] [PubMed] [Google Scholar]
  2. Bettaieb A., Oksenhendler E., Fromont P., Duedari N., Bierling P. Immunochemical analysis of platelet autoantibodies in HIV-related thrombocytopenic purpura: a study of 68 patients. Br J Haematol. 1989 Oct;73(2):241–247. doi: 10.1111/j.1365-2141.1989.tb00259.x. [DOI] [PubMed] [Google Scholar]
  3. Bost K. L., Hahn B. H., Saag M. S., Shaw G. M., Weigent D. A., Blalock J. E. Individuals infected with HIV possess antibodies against IL-2. Immunology. 1988 Dec;65(4):611–615. [PMC free article] [PubMed] [Google Scholar]
  4. Bottazzo G. F., Florin-Christensen A., Fairfax A., Swana G., Doniach D., Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol. 1976 May;29(5):403–410. doi: 10.1136/jcp.29.5.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bretherton L., Toh B. H. IgM autoantibody to intermediate filaments in infectious mononucleosis. J Clin Lab Immunol. 1981 Jan;5(1):7–10. [PubMed] [Google Scholar]
  6. Brown C., Pedersen J., Underwood J. R., Gust I., Toh B. H. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. J Clin Lab Immunol. 1986 Jan;19(1):1–4. [PubMed] [Google Scholar]
  7. Calabrese L. H. Autoimmune manifestations of human immunodeficiency virus (HIV) infection. Clin Lab Med. 1988 Jun;8(2):269–279. [PubMed] [Google Scholar]
  8. Cassani F., Bianchi F. B., Lenzi M., Volta U., Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol. 1985 Jul;38(7):801–805. doi: 10.1136/jcp.38.7.801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cassani F., Fusconi M., Bianchi F. B., Selleri L., Baffoni L., Lenzi M., Pisi E. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: relationship with anti-actin antibodies. Clin Exp Immunol. 1987 Jun;68(3):588–595. [PMC free article] [PubMed] [Google Scholar]
  10. Cohen H., Mackie I. J., Anagnostopoulos N., Savage G. F., Machin S. J. Lupus anticoagulant, anticardiolipin antibodies, and human immunodeficiency virus in haemophilia. J Clin Pathol. 1989 Jun;42(6):629–633. doi: 10.1136/jcp.42.6.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fujinami R. S., Oldstone M. B., Wroblewska Z., Frankel M. E., Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2346–2350. doi: 10.1073/pnas.80.8.2346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Golding H., Shearer G. M., Hillman K., Lucas P., Manischewitz J., Zajac R. A., Clerici M., Gress R. E., Boswell R. N., Golding B. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J Clin Invest. 1989 Apr;83(4):1430–1435. doi: 10.1172/JCI114034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kuo G., Choo Q. L., Alter H. J., Gitnick G. L., Redeker A. G., Purcell R. H., Miyamura T., Dienstag J. L., Alter M. J., Stevens C. E. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989 Apr 21;244(4902):362–364. doi: 10.1126/science.2496467. [DOI] [PubMed] [Google Scholar]
  14. Lane H. C., Fauci A. S. Immunologic abnormalities in the acquired immunodeficiency syndrome. Annu Rev Immunol. 1985;3:477–500. doi: 10.1146/annurev.iy.03.040185.002401. [DOI] [PubMed] [Google Scholar]
  15. Lane H. C., Masur H., Edgar L. C., Whalen G., Rook A. H., Fauci A. S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1983 Aug 25;309(8):453–458. doi: 10.1056/NEJM198308253090803. [DOI] [PubMed] [Google Scholar]
  16. Morrow W. J., Wharton M., Stricker R. B., Levy J. A. Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol. 1986 Sep;40(3):515–524. doi: 10.1016/0090-1229(86)90196-0. [DOI] [PubMed] [Google Scholar]
  17. Mortazavi-Milani S. M., Stierle H. E., Holborow E. J. In vitro induction of anti-intermediate filament antibody in lymphocyte cultures by Epstein-Barr virus. Immunol Lett. 1982 Oct;5(4):203–205. doi: 10.1016/0165-2478(82)90135-3. [DOI] [PubMed] [Google Scholar]
  18. Pedersen J. S., Toh B. H., Locarnini S. A., Gust I. D., Shyamala G. N. Autoantibody to intermediate filaments in viral hepatitis. Clin Immunol Immunopathol. 1981 Nov;21(2):154–161. doi: 10.1016/0090-1229(81)90204-x. [DOI] [PubMed] [Google Scholar]
  19. Pedersen J. S., Toh B. H., Mackay I. R., Tait B. D., Gust I. D., Kastelan A., Hadzic N. Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol. 1982 Jun;48(3):527–532. [PMC free article] [PubMed] [Google Scholar]
  20. Pruss R. M., Mirsky R., Raff M. C., Thorpe R., Dowding A. J., Anderton B. H. All classes of intermediate filaments share a common antigenic determinant defined by a monoclonal antibody. Cell. 1981 Dec;27(3 Pt 2):419–428. doi: 10.1016/0092-8674(81)90383-4. [DOI] [PubMed] [Google Scholar]
  21. Schnittman S. M., Lane H. C., Higgins S. E., Folks T., Fauci A. S. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science. 1986 Sep 5;233(4768):1084–1086. doi: 10.1126/science.3016902. [DOI] [PubMed] [Google Scholar]
  22. Seligmann M., Pinching A. J., Rosen F. S., Fahey J. L., Khaitov R. M., Klatzmann D., Koenig S., Luo N., Ngu J., Riethmüller G. Immunology of human immunodeficiency virus infection and the acquired immunodeficiency syndrome. An update. Ann Intern Med. 1987 Aug;107(2):234–242. doi: 10.7326/0003-4819-107-2-234. [DOI] [PubMed] [Google Scholar]
  23. Senecal J. L., Rothfield N. F., Oliver J. M. Immunoglobulin M autoantibody to vimentin intermediate filaments. J Clin Invest. 1982 Mar;69(3):716–721. doi: 10.1172/JCI110500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Silvestris F., Edwards B. S., Sadeghi O. M., Frassanito M. A., Williams R. C., Jr, Dammacco F. Isotype, distribution and target analysis of lymphocyte reactive antibodies in patients with human immunodeficiency virus infection. Clin Immunol Immunopathol. 1989 Nov;53(2 Pt 1):329–340. doi: 10.1016/0090-1229(89)90061-5. [DOI] [PubMed] [Google Scholar]
  25. Solinger A. M., Adams L. E., Friedman-Kien A. E., Hess E. V. Acquired immune deficiency syndrome (AIDS) and autoimmunity--mutually exclusive entities? J Clin Immunol. 1988 Jan;8(1):32–42. doi: 10.1007/BF00915154. [DOI] [PubMed] [Google Scholar]
  26. Stricker R. B., McHugh T. M., Moody D. J., Morrow W. J., Stites D. P., Shuman M. A., Levy J. A. An AIDS-related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4+ T cells. 1987 Jun 25-Jul 1Nature. 327(6124):710–713. doi: 10.1038/327710a0. [DOI] [PubMed] [Google Scholar]
  27. Tan E. M. Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol. 1982;33:167–240. doi: 10.1016/s0065-2776(08)60836-6. [DOI] [PubMed] [Google Scholar]
  28. Toh B. H. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol. 1979 Dec;38(3):621–628. [PMC free article] [PubMed] [Google Scholar]
  29. Toh B. H., Yildiz A., Sotelo J., Osung O., Holborow E. J., Kanakoudi F., Small J. V. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol. 1979 Jul;37(1):76–82. [PMC free article] [PubMed] [Google Scholar]
  30. Viac J., Paire J., Desgranges C., Iwatsuki K., Thivolet J. Epstein-Barr virus-transformed lymphocytes from patients with bullous diseases produce autoantibodies to cytokeratins. Clin Immunol Immunopathol. 1986 May;39(2):277–284. doi: 10.1016/0090-1229(86)90091-7. [DOI] [PubMed] [Google Scholar]
  31. Winchester R., Bernstein D. H., Fischer H. D., Enlow R., Solomon G. The co-occurrence of Reiter's syndrome and acquired immunodeficiency. Ann Intern Med. 1987 Jan;106(1):19–26. doi: 10.7326/0003-4819-106-1-19. [DOI] [PubMed] [Google Scholar]
  32. Yarchoan R., Redfield R. R., Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest. 1986 Aug;78(2):439–447. doi: 10.1172/JCI112595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zauli D., Crespi C., Bianchi F. B., Craxi A., Pisi E. Autoimmunity in chronic liver disease caused by hepatitis delta virus. J Clin Pathol. 1986 Aug;39(8):897–899. doi: 10.1136/jcp.39.8.897. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES